A new therapeutic target for myelofibrosis is cause for Gli

Research output: Contribution to journalReview article

Abstract

Myeloproliferative neoplasm cells recruit Gli1 positive mesenchymal stromal cells to transdifferentiate into fibrosis-causing myofibroblasts, a process that can be inhibited by a Gli inhibitor.

Original languageEnglish (US)
Article numberaan4297
JournalScience Translational Medicine
Volume9
Issue number392
DOIs
StatePublished - May 31 2017

    Fingerprint

ASJC Scopus subject areas

  • Medicine(all)

Cite this